https://www.ambagontx.com/
Ambagon Therapeutics • The 14-3-3 Molecular Glue Company
Jan 12, 2023 - Ambagon’s approach selectively augments the endogenous tumor suppression activity of 14-3-3 proteins bound to transcription factors and oncoproteins that have...
molecular gluetherapeuticscompany